Drug policy and drug legislation in South East Europe. Publication of Diogenis

The Association Diogenis, issued a volume containing reports of ten countries of the South East European Region on drug policy and drug legislation. The volume was published by the publishing house “Legal Library” in Athens. The country reports are published separately on this website. The volume has been issued in the framework of the Project “Drug Law Reform in South East Europe”
The reports per country describe the current National Strategy on Drugs, the national substantive criminal law, the national drug laws and institutions, Drug law enforcement in practice, sentencing levels and the prison situation, initiatives for drug law reform undertaken by the government(s) and/or parliament(s) in recent years and proposals and recommendations for further research and advocacy work.


The Association Diogenis aims to promote policies based on respect for human rights, scientific evidence and best practices which would provide a framework for a more balanced approach and will result in a more effective policy and practice. A major concern of the activities is to encourage open debate on drug policy reform and raise public awareness regarding the current drug policies, their ineffectiveness and their adverse consequences for individuals and society.
The project “Drug Law Reform in South East Europe” and the other activities of the Diogenis Association are an effort to connect developments and initiatives in the SEE region with the European Unionʼs Drug Strategy and Action Plan as well as with global developments on Drug Policy.
After several decades of implementation of the current international drug control system, there is worldwide a sense of urgency to adjust the system, correct the aspects that cause adverse consequences and make it more effective. Open dialogue with the relevant authorities responsible for Drug Policy is essential in the search for more humane and effective Drug Policies and practice. The critical voices of civil society organisations such as the NGOs must be seen as a complementary contribution to the Drug Policy debate. Our cooperation with research institutes and universities is growing and there is mutual appreciation of our activities. The combination of the NGOs practical experience in the field and the scientific insights of researchers is a valuable contribution to the drug policy debate. It is up to the policy makers and governments to make use of proposals and recommendations and incorporate suggestions in Strategic choices and Legislation.

You can download the book for free, here.